- Home
- CMU vs PMVP Comparison
CMU vs PMVP Comparison
Compare CMU & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMU | PMVP |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.5M | 66.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CMU | PMVP |
|---|---|---|
| Price | $3.49 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 82.4K | ★ 278.2K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $47.57 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.78 | $0.81 |
| 52 Week High | $3.38 | $1.84 |
Technical Indicators
Market Signals| Indicator | CMU | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 50.99 | 45.01 |
| Support Level | $3.45 | $1.20 |
| Resistance Level | $3.51 | $1.28 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 66.67 | 55.00 |
Price Performance
Historical ComparisonAbout CMU MFS Municipal Income Trust
Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes. The company invest various top Healthcare companies, Airport, Universities (Secondary Schools), Universities (Dormitories), and many more, out of maximum revenue is gained from Healthcare Hospitals and Long Term Care.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.